OtherArticle
Human α6β4 nicotinic acetylcholine receptor: heterologous expression and agonist behavior provide insights into the immediate binding site
Maria Constanza Maldifassi, Hugo Rego Campello, Timothy Gallagher, Henry A. Lester and Dennis A Dougherty
Molecular Pharmacology March 31, 2023, MOLPHARM-AR-2023-000672; DOI: https://doi.org/10.1124/molpharm.123.000672
Maria Constanza Maldifassi
1Institute of Biochemistry and Molecular Medicine, University of Bern, Switzerland
Hugo Rego Campello
2School of Chemistry, University of Bristol, United Kingdom
Timothy Gallagher
2School of Chemistry, University of Bristol, United Kingdom
Henry A. Lester
3Division of Biology & Biological Engineering, California Institute of Technology, United States
Dennis A Dougherty
4Division of Chemistry and Chemical Engineering, California Institute of Technology, United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Pharmacological characterization of the human α6β4 nAChR
Maria Constanza Maldifassi, Hugo Rego Campello, Timothy Gallagher, Henry A. Lester and Dennis A Dougherty
Molecular Pharmacology March 31, 2023, MOLPHARM-AR-2023-000672; DOI: https://doi.org/10.1124/molpharm.123.000672
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement